News and features

Why we're worried that EU rules on drug trials are denying children with cancer new, potentially life-saving drugs.

A gift of £110,000 from charity Abbie's Army is helping to fund a talented young scientist, who recently won an award for her research into childhood brain cancer.

ICR scientists find a genetic link between multiple myeloma and a mysterious but harmless condition affecting the blood.

Scientists from The Institute of Cancer Research, London, have outlined their new method to separate paired embryonic stem cells.

A new drug – combined with cytotoxic and targeted chemotherapies – has been shown to be safe for patients with advanced solid tumours.

The ICR's Deputy CEO has been honoured with an international award for excellence in cancer research.

A study into a unique breast cancer sub-type called micropapillary carcinoma of the breast has given new clues to its genetic make-up.

Darwin’s theory of evolution by natural selection – a force of nature favouring those carrying advantageous traits and making those traits more common in the next generation – is the central paradigm of biology. Darwin developed this idea to explain the origins of the extraordinary diversity of species on the planet. But it turns out that exactly the same fundamental principle applies to many areas of health and disease, including antibiotic resistance, the emergence of new infectious diseases, the functioning of our immune systems and, not least, cancer.

Professor Mel Greaves FRS talks to us about why The Institute of Cancer Research is launching The Centre for Evolution and Cancer.

ICR researchers pioneer scanning technique that can image a patient’s entire body to reveal where cancer is affecting the bones.

Professor Paul Workman, has been elected as a Fellow of the European Academy of Cancer Sciences

Researchers have shed new light on how DNA damage is repaired within cells, in work with important implications for cancer prevention and treatment.